Screening for lipid disorders in children and adolescents US Preventive Services Task Force recommendation statement

Kirsten Bibbins-Domingo, David C. Grossman, Susan J. Curry, Karina W. Davidson, John W. Epling, Francisco A Garcia, Matthew W. Gillman, Alex R. Kemper, Alex H. Krist, Ann E. Kurth, C. Seth Landefeld, Michael LeFevre, Carol M. Mangione, William R. Phillips, Maureen G. Phipps, Michael P. Pignone, Albert L. Siu

Research output: Contribution to journalArticle

52 Citations (Scopus)

Abstract

IMPORTANCE: Elevations in levels of total, low-density lipoprotein, and non-high-density lipoprotein cholesterol; lower levels of high-density lipoprotein cholesterol; and, to a lesser extent, elevated triglyceride levels are associated with risk of cardiovascular disease in adults. OBJECTIVE: To update the 2007 US Preventive Services Task Force (USPSTF) recommendation on screening for lipid disorders in children, adolescents, and young adults. EVIDENCE REVIEW: The USPSTF reviewed the evidence on screening for lipid disorders in children and adolescents 20 years or younger-1 review focused on screening for heterozygous familial hypercholesterolemia, and 1 review focused on screening for multifactorial dyslipidemia. FINDINGS: Evidence on the quantitative difference in diagnostic yield between universal and selective screening approaches, the effectiveness and harms of long-term treatment and the harms of screening, and the association between changes in intermediate outcomes and improvements in adult cardiovascular health outcomes are limited. Therefore, the USPSTF concludes that the balance of benefits and harms cannot be determined. CONCLUSIONS AND RECOMMENDATION: The USPSTF concludes that the current evidence is insufficient to assess the balance of benefits and harms of screening for lipid disorders in children and adolescents 20 years or younger. (I statement).

Original languageEnglish (US)
Pages (from-to)625-633
Number of pages9
JournalJAMA - Journal of the American Medical Association
Volume316
Issue number6
DOIs
StatePublished - Aug 9 2016

Fingerprint

Advisory Committees
Lipids
Hyperlipoproteinemia Type II
Dyslipidemias
LDL Lipoproteins
HDL Cholesterol
Young Adult
Triglycerides
Cardiovascular Diseases
Health
Therapeutics

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Screening for lipid disorders in children and adolescents US Preventive Services Task Force recommendation statement. / Bibbins-Domingo, Kirsten; Grossman, David C.; Curry, Susan J.; Davidson, Karina W.; Epling, John W.; Garcia, Francisco A; Gillman, Matthew W.; Kemper, Alex R.; Krist, Alex H.; Kurth, Ann E.; Seth Landefeld, C.; LeFevre, Michael; Mangione, Carol M.; Phillips, William R.; Phipps, Maureen G.; Pignone, Michael P.; Siu, Albert L.

In: JAMA - Journal of the American Medical Association, Vol. 316, No. 6, 09.08.2016, p. 625-633.

Research output: Contribution to journalArticle

Bibbins-Domingo, K, Grossman, DC, Curry, SJ, Davidson, KW, Epling, JW, Garcia, FA, Gillman, MW, Kemper, AR, Krist, AH, Kurth, AE, Seth Landefeld, C, LeFevre, M, Mangione, CM, Phillips, WR, Phipps, MG, Pignone, MP & Siu, AL 2016, 'Screening for lipid disorders in children and adolescents US Preventive Services Task Force recommendation statement', JAMA - Journal of the American Medical Association, vol. 316, no. 6, pp. 625-633. https://doi.org/10.1001/jama.2016.9852
Bibbins-Domingo, Kirsten ; Grossman, David C. ; Curry, Susan J. ; Davidson, Karina W. ; Epling, John W. ; Garcia, Francisco A ; Gillman, Matthew W. ; Kemper, Alex R. ; Krist, Alex H. ; Kurth, Ann E. ; Seth Landefeld, C. ; LeFevre, Michael ; Mangione, Carol M. ; Phillips, William R. ; Phipps, Maureen G. ; Pignone, Michael P. ; Siu, Albert L. / Screening for lipid disorders in children and adolescents US Preventive Services Task Force recommendation statement. In: JAMA - Journal of the American Medical Association. 2016 ; Vol. 316, No. 6. pp. 625-633.
@article{e30df005f48041428cf69e1dff233f2d,
title = "Screening for lipid disorders in children and adolescents US Preventive Services Task Force recommendation statement",
abstract = "IMPORTANCE: Elevations in levels of total, low-density lipoprotein, and non-high-density lipoprotein cholesterol; lower levels of high-density lipoprotein cholesterol; and, to a lesser extent, elevated triglyceride levels are associated with risk of cardiovascular disease in adults. OBJECTIVE: To update the 2007 US Preventive Services Task Force (USPSTF) recommendation on screening for lipid disorders in children, adolescents, and young adults. EVIDENCE REVIEW: The USPSTF reviewed the evidence on screening for lipid disorders in children and adolescents 20 years or younger-1 review focused on screening for heterozygous familial hypercholesterolemia, and 1 review focused on screening for multifactorial dyslipidemia. FINDINGS: Evidence on the quantitative difference in diagnostic yield between universal and selective screening approaches, the effectiveness and harms of long-term treatment and the harms of screening, and the association between changes in intermediate outcomes and improvements in adult cardiovascular health outcomes are limited. Therefore, the USPSTF concludes that the balance of benefits and harms cannot be determined. CONCLUSIONS AND RECOMMENDATION: The USPSTF concludes that the current evidence is insufficient to assess the balance of benefits and harms of screening for lipid disorders in children and adolescents 20 years or younger. (I statement).",
author = "Kirsten Bibbins-Domingo and Grossman, {David C.} and Curry, {Susan J.} and Davidson, {Karina W.} and Epling, {John W.} and Garcia, {Francisco A} and Gillman, {Matthew W.} and Kemper, {Alex R.} and Krist, {Alex H.} and Kurth, {Ann E.} and {Seth Landefeld}, C. and Michael LeFevre and Mangione, {Carol M.} and Phillips, {William R.} and Phipps, {Maureen G.} and Pignone, {Michael P.} and Siu, {Albert L.}",
year = "2016",
month = "8",
day = "9",
doi = "10.1001/jama.2016.9852",
language = "English (US)",
volume = "316",
pages = "625--633",
journal = "JAMA - Journal of the American Medical Association",
issn = "0002-9955",
publisher = "American Medical Association",
number = "6",

}

TY - JOUR

T1 - Screening for lipid disorders in children and adolescents US Preventive Services Task Force recommendation statement

AU - Bibbins-Domingo, Kirsten

AU - Grossman, David C.

AU - Curry, Susan J.

AU - Davidson, Karina W.

AU - Epling, John W.

AU - Garcia, Francisco A

AU - Gillman, Matthew W.

AU - Kemper, Alex R.

AU - Krist, Alex H.

AU - Kurth, Ann E.

AU - Seth Landefeld, C.

AU - LeFevre, Michael

AU - Mangione, Carol M.

AU - Phillips, William R.

AU - Phipps, Maureen G.

AU - Pignone, Michael P.

AU - Siu, Albert L.

PY - 2016/8/9

Y1 - 2016/8/9

N2 - IMPORTANCE: Elevations in levels of total, low-density lipoprotein, and non-high-density lipoprotein cholesterol; lower levels of high-density lipoprotein cholesterol; and, to a lesser extent, elevated triglyceride levels are associated with risk of cardiovascular disease in adults. OBJECTIVE: To update the 2007 US Preventive Services Task Force (USPSTF) recommendation on screening for lipid disorders in children, adolescents, and young adults. EVIDENCE REVIEW: The USPSTF reviewed the evidence on screening for lipid disorders in children and adolescents 20 years or younger-1 review focused on screening for heterozygous familial hypercholesterolemia, and 1 review focused on screening for multifactorial dyslipidemia. FINDINGS: Evidence on the quantitative difference in diagnostic yield between universal and selective screening approaches, the effectiveness and harms of long-term treatment and the harms of screening, and the association between changes in intermediate outcomes and improvements in adult cardiovascular health outcomes are limited. Therefore, the USPSTF concludes that the balance of benefits and harms cannot be determined. CONCLUSIONS AND RECOMMENDATION: The USPSTF concludes that the current evidence is insufficient to assess the balance of benefits and harms of screening for lipid disorders in children and adolescents 20 years or younger. (I statement).

AB - IMPORTANCE: Elevations in levels of total, low-density lipoprotein, and non-high-density lipoprotein cholesterol; lower levels of high-density lipoprotein cholesterol; and, to a lesser extent, elevated triglyceride levels are associated with risk of cardiovascular disease in adults. OBJECTIVE: To update the 2007 US Preventive Services Task Force (USPSTF) recommendation on screening for lipid disorders in children, adolescents, and young adults. EVIDENCE REVIEW: The USPSTF reviewed the evidence on screening for lipid disorders in children and adolescents 20 years or younger-1 review focused on screening for heterozygous familial hypercholesterolemia, and 1 review focused on screening for multifactorial dyslipidemia. FINDINGS: Evidence on the quantitative difference in diagnostic yield between universal and selective screening approaches, the effectiveness and harms of long-term treatment and the harms of screening, and the association between changes in intermediate outcomes and improvements in adult cardiovascular health outcomes are limited. Therefore, the USPSTF concludes that the balance of benefits and harms cannot be determined. CONCLUSIONS AND RECOMMENDATION: The USPSTF concludes that the current evidence is insufficient to assess the balance of benefits and harms of screening for lipid disorders in children and adolescents 20 years or younger. (I statement).

UR - http://www.scopus.com/inward/record.url?scp=84981229108&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84981229108&partnerID=8YFLogxK

U2 - 10.1001/jama.2016.9852

DO - 10.1001/jama.2016.9852

M3 - Article

C2 - 27532917

AN - SCOPUS:84981229108

VL - 316

SP - 625

EP - 633

JO - JAMA - Journal of the American Medical Association

JF - JAMA - Journal of the American Medical Association

SN - 0002-9955

IS - 6

ER -